Histogen Inc.
HSTO · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | 0% | 25% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,140% | -660% | -660% | -850% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -76,600% | -41,000% | -68,720% | -73,250% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -77,020% | -41,840% | -69,460% | -74,675% |
| EPS Diluted | -0.9 | -0.49 | -0.81 | -0.93 |
| % Growth | -83.7% | 39.5% | 12.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |